Galmed Pharmaceuticals Ltd.

Ticker GLMD

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Tel Aviv, Israel

Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase III registrational study.

Visit website

REPORT RATINGS

4.8 / 5.0 (78)

Galmed Pharmaceuticals Ltd. reports have an aggregate usefulness score of 4.8 based on 78 reviews.

Galmed Pharmaceuticals Ltd.